The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALNYLAM PHARMACEUTICALS INC COM 02043Q107 2,684 25,700 SH   DFND   25,700 0 0
AMERCO COM 023586100 11,968 36,223 SH   DFND   36,223 0 0
CAMBREX CORP COM 132011107 8,104 204,500 SH   DFND   204,500 0 0
CAMBIUM LEARNING GRP INC COM 13201A107 316 100,000 SH   DFND   100,000 0 0
CAPITAL SOUTHWEST CORP COM 140501107 15,334 330,322 SH   DFND   330,322 0 0
DICERNA PHARMACEUTICALS INC COM 253031108 2,960 123,200 SH   DFND   123,200 0 0
WINTHROP RLTY TR SH BEN INT NEW 976391300 7,769 476,066 SH   DFND   476,066 0 0
TARO PHARMACEUTICAL INDS LTD SHS M8737E108 142,543 1,010,727 SH   DFND   1,010,727 0 0
TOWER SEMICONDUCTOR LTD SHS NEW M87915274 12,895 759,400 SH   DFND   759,400 0 0